Study Investigating the Effect of Idalopirdine on Cardiac Repolarisation in Healthy Men

NCT02436486 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

76

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: Placebo
DRUG: ldalopirdine 120 mg
DRUG: Idalopirdine 360 mg
DRUG: Moxifloxacin 400 mg

Sponsor

H. Lundbeck A/S